Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunotherapy for Behçet's disease

¹Department of Ophthalmology, Kurume University School of Medicine, Fukuoka, Japan.

International Reviews of Immunology

|January 1, 1997

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients.

Clinical and experimental immunology·1995

Same author

Inducible expression of a gene encoding an L41 ribosomal protein responsible for the cycloheximide-resistant phenotype in the yeast Candida maltosa.

Journal of bacteriology·1995

Same author

Intracranial meningioma masquerading as a primary pleuropulmonary tumor.

Pathology international·1995

Same author

Mitochondrial encephalomyopathy with A to G transition of mitochondrial transfer RNA(Leu(UUR)) 3,243 presenting hypertrophic cardiomyopathy.

Internal medicine (Tokyo, Japan)·1995

Same author

[Differential patterns of the number and proportion of blood leukocytes following endurance exercise of moderate, strenuous and severe conditions].

Nihon eiseigaku zasshi. Japanese journal of hygiene·1995

Same author

Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis.

Experimental eye research·1995

Behçet's disease, an inflammatory disorder, involves immune system alterations. This review analyzes immunosuppressive drugs like corticosteroids and cyclosporine for treating this sight-threatening condition.

Area of Science:

Immunology
Ophthalmology
Rheumatology

Background:

Behçet's disease is a multi-organ inflammatory disorder.
It is a leading cause of sight-threatening conditions in Mediterranean and Asian regions.
Immune system dysregulation, including T-cell and leukocyte abnormalities, is central to its pathology.

Purpose of the Study:

To review experimental and clinical studies on immunosuppressive agents for Behçet's disease.
To analyze the immunopharmacological activities of these agents.

Main Methods:

Review of existing literature on immunosuppressive treatments.
Analysis of data from animal models and human patients.

Main Results:

Related Experiment Videos

Various immunosuppressive agents are used, including corticosteroids, colchicine, cytotoxic drugs, and immunophilin ligands (cyclosporine, FK506).

These drugs modulate immune responses implicated in Behçet's disease pathogenesis.

Conclusions:

Immunosuppressive therapies are crucial for managing Behçet's disease.
Further understanding of immunopharmacology can optimize treatment strategies.